JoVE Logo

S'identifier

17.9 : Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric repeat sequence and enables repetitive cell division; however, in adults, telomerase is active only in the cells that need to divide regularly.

Because telomerase is inactive in most human somatic cells, the length of the telomere decreases with every cell division. After a critical length, telomere shortening leads to permanent cell cycle arrest. This mechanism is assumed to protect against cancer development by limiting the abnormal proliferation of tumors; however, a rare mutation can activate telomerase, which reconstructs the telomere region, allowing the cells to proliferate. Thus, telomerase is a perfect target for specific anticancer therapy, as most cancer cells express telomerase while normal cells do not.

The relation between telomere length and tumor formation has been experimentally verified using oncogenic mice. Oncogenic mice are mouse models that have cancer-causing genes. When such oncogenic mice are crossed with telomerase-deficient mice that lack telomerase activity, the resultant progeny mice express shorter telomeres than the oncogenic parent. These progeny mice, when interbred, generate successive generations that have progressively shorter telomeres. The frequency of tumor formation is studied by treating the progeny mice with carcinogens at every generation. As per the results, the late generation mice with shorter telomeres exhibit a reduced frequency of tumor formation compared to the early generation mice that maintain longer telomeres. This proves that limiting the replicative capacity of cells suppresses tumor formation.

Tags

Replicative Cell SenescenceFinite Number Of Cell DivisionsTelomereRepetitive DNA SequencesProtective Cap On ChromosomesTelomeraseSomatic CellsTelomere ShorteningPermanent Cell Cycle ArrestCancer DevelopmentAnticancer TherapyTelomerase Expression In Cancer CellsTelomere Length And Tumor FormationOncogenic Mice

Du chapitre 17:

article

Now Playing

17.9 : Replicative Cell Senescence

Prolifération cellulaire

3.6K Vues

article

17.1 : Qu’est-ce que le cycle cellulaire ?

Prolifération cellulaire

10.1K Vues

article

17.2 : Interphase

Prolifération cellulaire

4.4K Vues

article

17.3 : Le système de contrôle du cycle cellulaire

Prolifération cellulaire

11.9K Vues

article

17.4 : Molécules régulatrices positives

Prolifération cellulaire

5.3K Vues

article

17.5 : Inhibition de l’activité CDK

Prolifération cellulaire

4.6K Vues

article

17.6 : S-Cdk initie la réplication de l’ADN

Prolifération cellulaire

4.6K Vues

article

17.7 : M-Cdk induit la transition en mitose

Prolifération cellulaire

5.5K Vues

article

17.8 : Mitogènes et le cycle cellulaire

Prolifération cellulaire

6.3K Vues

article

17.10 : Prolifération anormale

Prolifération cellulaire

4.4K Vues

article

17.11 : Les cellules coordonnent la croissance et la prolifération

Prolifération cellulaire

4.4K Vues

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.